NCLEX | VEXPX | NCLEX / VEXPX | |
Total Expense Ratio | 0.85 | 0.44 | 193% |
Annual Report Gross Expense Ratio | 0.85 | 0.44 | 193% |
Fund Existence | 38 years | 58 years | - |
Gain YTD | -5.902 | 1.235 | -478% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 3000 | 3,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 444M | 19.9B | 2% |
Annual Yield % from dividends | 0.00 | 0.40 | - |
Returns for 1 year | -4.16 | -1.90 | 220% |
Returns for 3 years | -5.99 | 5.40 | -111% |
Returns for 5 years | -2.86 | 5.07 | -56% |
Returns for 10 years | 8.35 | 19.92 | 42% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GSEE | 52.32 | 0.08 | +0.15% |
Goldman Sachs MarketBeta Emer Mkt Eq ETF | |||
XTJA | 30.25 | N/A | N/A |
Innovator US Equity Acclrtd Pls ETF Jan | |||
QMAR | 31.69 | -0.02 | -0.05% |
FT Vest Nasdaq-100 Buffer ETF – Mar | |||
CSQ | 18.41 | -0.08 | -0.43% |
Calamos Strategic Total Return | |||
SPYQ | 147.21 | -0.99 | -0.67% |
Tradr 2X Long SPY Quarterly ETF |